(Q45756790)

15 December 2017

title

Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis (English)

1 reference

15 December 2017

author

Michael P. Lux

7

1 reference

15 December 2017

Stefan P Renner

Stefan P Renner

16

0 references

Alexander Hein

Alexander Hein

12

0 references

Peter A. Fasching

5

Peter A Fasching

1 reference

15 December 2017

18

Matthias W Beckmann

1 reference

15 December 2017

17

Arndt Hartmann

1 reference

15 December 2017

Katharina Heusinger

13

Katharina Heusinger

1 reference

15 December 2017

Lothar Haeberle

4

Lothar Haeberle

1 reference

15 December 2017

Christian M Bayer

11

Christian M Bayer

1 reference

15 December 2017

Michael G Schrauder

9

Michael G Schrauder

1 reference

15 December 2017

author name string

Christian R Loehberg

1

1 reference

15 December 2017

Katrin Almstedt

2

1 reference

15 December 2017

Sebastian M Jud

3

1 reference

15 December 2017

Carolin C Hack

6

1 reference

15 December 2017

Falk C Thiel

8

1 reference

15 December 2017

Michaela Brunner

10

1 reference

15 December 2017

Jutta Heimrich

14

1 reference

15 December 2017

Mayada R Bani

15

1 reference

15 December 2017

David L Wachter

19

1 reference

15 December 2017

language of work or name

English

0 references

publication date

12 March 2013

1 reference

15 December 2017

Breast Cancer Research and Treatment

published in

1 reference

15 December 2017

volume

138

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

899-908

1 reference

15 December 2017

Prognostic factors in 1,038 women with metastatic breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Receptor conversion in distant breast cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Construction and validation of a practical prognostic index for patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Clinical course and prognostic factors following bone recurrence from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Multivariate analysis of prognostic factors in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Survival after first recurrence of breast cancer. The Miami experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Estrogen and progestin regulation of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

The biology of progesterone receptor in the normal mammary gland and in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Impact of metastatic estrogen receptor and progesterone receptor status on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Progesterone receptor status of breast cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2460-Y

10.1007/S10549-013-2460-Y

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

1013604887

0 references

1 reference

15 December 2017